Phillips Katharine A
Brown Medical School and Butler Hospital, 345 Blackstone Blvd., Providence, Rhode Island 02906, USA.
World Psychiatry. 2004 Feb;3(1):12-7.
Body dysmorphic disorder (BDD), also known as dysmorphophobia, is a severe psychiatric disorder that occurs around the world. However, the diagnosis is usually missed in clinical settings. It is important to recognize and diagnose BDD, because this disorder is relatively common and causes significant distress and impairment in functioning. It is also associated with markedly poor quality of life. Although research on effective treatment is still limited, serotonin reuptake inhibitors (SRIs) are currently considered the medication treatment of choice. For symptoms to improve, a relatively high SRI dose and at least 12 weeks of treatment is often needed. The psychosocial treatment of choice is cognitive behavioral therapy, consisting of elements such as exposure, response prevention, behavioral experiments, and cognitive restructuring. Although knowledge of BDD is rapidly increasing, further research is needed on all aspects of this disorder, including treatment studies, epidemiology studies, and investigation of its cross-cultural features and pathogenesis.
躯体变形障碍（BDD），也称为畸形恐惧症，是一种在全球范围内发生的严重精神疾病。然而，在临床环境中，该诊断通常会被漏诊。识别和诊断BDD很重要，因为这种疾病相对常见，会导致严重的痛苦和功能损害。它还与明显较差的生活质量相关。尽管关于有效治疗的研究仍然有限，但血清素再摄取抑制剂（SRIs）目前被认为是首选的药物治疗方法。为了使症状改善，通常需要相对较高剂量的SRIs以及至少12周的治疗。首选的心理社会治疗方法是认知行为疗法，包括暴露、反应预防、行为实验和认知重构等要素。尽管对BDD的认识正在迅速增加，但仍需要对这种疾病的各个方面进行进一步研究，包括治疗研究、流行病学研究以及对其跨文化特征和发病机制的调查。
